Annual EBIT
-$12.23 M
+$23.07 M+65.35%
31 December 2023
Summary:
Pieris Pharmaceuticals annual earnings before interest & taxes is currently -$12.23 million, with the most recent change of +$23.07 million (+65.35%) on 31 December 2023. During the last 3 years, it has risen by +$21.69 million (+63.94%). PIRS annual EBIT is now -2283.90% below its all-time high of $944.80 thousand.PIRS EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$3.13 M
+$1.04 M+24.95%
30 September 2024
Summary:
Pieris Pharmaceuticals quarterly earnings before interest & taxes is currently -$3.13 million, with the most recent change of +$1.04 million (+24.95%) on 30 September 2024. Over the past year, it has dropped by -$6.22 million (-201.59%). PIRS quarterly EBIT is now -148.32% below its all-time high of $6.49 million, reached on 31 December 2017.PIRS Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$18.10 M
-$6.22 M-52.38%
30 September 2024
Summary:
Pieris Pharmaceuticals TTM earnings before interest & taxes is currently -$18.10 million, with the most recent change of -$6.22 million (-52.38%) on 30 September 2024. Over the past year, it has dropped by -$3.22 million (-21.64%). PIRS TTM EBIT is now -311917.24% below its all-time high of -$5800.00, reached on 30 September 2013.PIRS TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PIRS EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +65.3% | -201.6% | -21.6% |
| 3 y3 years | +63.9% | +81.8% | +64.3% |
| 5 y5 years | +60.3% | -7.6% | +53.0% |
PIRS EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +74.6% | -186.0% | +81.8% | -346.6% | +64.3% |
| 5 y | 5 years | at high | +74.6% | -186.0% | +81.8% | -346.6% | +64.3% |
| alltime | all time | -2283.9% | +74.6% | -148.3% | +81.8% | <-9999.0% | +64.3% |
Pieris Pharmaceuticals EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$3.13 M(-24.9%) | -$18.10 M(+52.4%) |
| June 2024 | - | -$4.18 M(-21.2%) | -$11.88 M(+193.1%) |
| Mar 2024 | - | -$5.30 M(-3.3%) | -$4.05 M(-66.9%) |
| Dec 2023 | -$12.23 M(-65.3%) | -$5.48 M(-277.6%) | -$12.23 M(-17.8%) |
| Sept 2023 | - | $3.09 M(-15.4%) | -$14.88 M(-48.1%) |
| June 2023 | - | $3.65 M(-127.0%) | -$28.66 M(-34.0%) |
| Mar 2023 | - | -$13.48 M(+65.9%) | -$43.46 M(+23.9%) |
| Dec 2022 | -$35.30 M(-26.7%) | -$8.13 M(-24.0%) | -$35.07 M(-4.8%) |
| Sept 2022 | - | -$10.70 M(-4.0%) | -$36.85 M(-15.0%) |
| June 2022 | - | -$11.15 M(+118.6%) | -$43.37 M(-10.0%) |
| Mar 2022 | - | -$5.10 M(-48.5%) | -$48.19 M(+0.1%) |
| Dec 2021 | -$48.15 M(+41.9%) | -$9.90 M(-42.5%) | -$48.15 M(-4.9%) |
| Sept 2021 | - | -$17.22 M(+7.8%) | -$50.65 M(+9.1%) |
| June 2021 | - | -$15.96 M(+215.6%) | -$46.43 M(+32.2%) |
| Mar 2021 | - | -$5.06 M(-59.2%) | -$35.12 M(+3.5%) |
| Dec 2020 | -$33.92 M(+24.9%) | -$12.41 M(-4.5%) | -$33.92 M(+48.5%) |
| Sept 2020 | - | -$13.00 M(+179.2%) | -$22.84 M(+79.1%) |
| June 2020 | - | -$4.66 M(+20.7%) | -$12.76 M(-37.3%) |
| Mar 2020 | - | -$3.86 M(+189.9%) | -$20.33 M(-25.1%) |
| Dec 2019 | -$27.16 M(-11.9%) | -$1.33 M(-54.4%) | -$27.16 M(-29.4%) |
| Sept 2019 | - | -$2.91 M(-76.2%) | -$38.48 M(-11.3%) |
| June 2019 | - | -$12.23 M(+14.5%) | -$43.37 M(+29.9%) |
| Mar 2019 | - | -$10.68 M(-15.5%) | -$33.38 M(+8.3%) |
| Dec 2018 | -$30.83 M | -$12.65 M(+62.1%) | -$30.83 M(+163.6%) |
| Sept 2018 | - | -$7.80 M(+247.9%) | -$11.70 M(+28.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2018 | - | -$2.24 M(-72.4%) | -$9.07 M(-38.4%) |
| Mar 2018 | - | -$8.14 M(-225.4%) | -$14.72 M(+0.9%) |
| Dec 2017 | -$14.59 M(-35.9%) | $6.49 M(-225.2%) | -$14.59 M(-46.9%) |
| Sept 2017 | - | -$5.18 M(-34.3%) | -$27.49 M(-3.5%) |
| June 2017 | - | -$7.89 M(-1.4%) | -$28.48 M(+7.9%) |
| Mar 2017 | - | -$8.01 M(+25.0%) | -$26.38 M(+15.9%) |
| Dec 2016 | -$22.76 M(+66.4%) | -$6.40 M(+3.7%) | -$22.76 M(+20.3%) |
| Sept 2016 | - | -$6.18 M(+6.6%) | -$18.92 M(+13.8%) |
| June 2016 | - | -$5.80 M(+32.3%) | -$16.63 M(+15.8%) |
| Mar 2016 | - | -$4.38 M(+70.5%) | -$14.36 M(+5.0%) |
| Dec 2015 | -$13.68 M(+90.1%) | -$2.57 M(-33.8%) | -$13.68 M(+23.1%) |
| Sept 2015 | - | -$3.88 M(+10.0%) | -$11.11 M(+53.4%) |
| June 2015 | - | -$3.53 M(-4.6%) | -$7.24 M(+94.7%) |
| Mar 2015 | - | -$3.70 M(>+9900.0%) | -$3.72 M(>+9900.0%) |
| Dec 2014 | -$7.20 M(>+9900.0%) | - | - |
| Sept 2014 | - | -$13.90 K(+124.2%) | -$23.80 K(+51.6%) |
| June 2014 | - | -$6200.00(+313.3%) | -$15.70 K(+65.3%) |
| June 2014 | -$15.70 K(-102.8%) | - | - |
| Mar 2014 | - | -$1500.00(-31.8%) | -$9500.00(+18.8%) |
| Dec 2013 | $560.10 K(<-9900.0%) | -$2200.00(-62.1%) | -$8000.00(+37.9%) |
| Sept 2013 | - | -$5800.00 | -$5800.00 |
| June 2013 | -$300.00(-98.6%) | - | - |
| June 2003 | -$21.30 K(-9.4%) | - | - |
| June 2002 | -$23.50 K(+190.1%) | - | - |
| June 2001 | -$8100.00 | - | - |
FAQ
- What is Pieris Pharmaceuticals annual earnings before interest & taxes?
- What is the all time high annual EBIT for Pieris Pharmaceuticals?
- What is Pieris Pharmaceuticals annual EBIT year-on-year change?
- What is Pieris Pharmaceuticals quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Pieris Pharmaceuticals?
- What is Pieris Pharmaceuticals quarterly EBIT year-on-year change?
- What is Pieris Pharmaceuticals TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Pieris Pharmaceuticals?
- What is Pieris Pharmaceuticals TTM EBIT year-on-year change?
What is Pieris Pharmaceuticals annual earnings before interest & taxes?
The current annual EBIT of PIRS is -$12.23 M
What is the all time high annual EBIT for Pieris Pharmaceuticals?
Pieris Pharmaceuticals all-time high annual earnings before interest & taxes is $944.80 K
What is Pieris Pharmaceuticals annual EBIT year-on-year change?
Over the past year, PIRS annual earnings before interest & taxes has changed by +$23.07 M (+65.35%)
What is Pieris Pharmaceuticals quarterly earnings before interest & taxes?
The current quarterly EBIT of PIRS is -$3.13 M
What is the all time high quarterly EBIT for Pieris Pharmaceuticals?
Pieris Pharmaceuticals all-time high quarterly earnings before interest & taxes is $6.49 M
What is Pieris Pharmaceuticals quarterly EBIT year-on-year change?
Over the past year, PIRS quarterly earnings before interest & taxes has changed by -$6.22 M (-201.59%)
What is Pieris Pharmaceuticals TTM earnings before interest & taxes?
The current TTM EBIT of PIRS is -$18.10 M
What is the all time high TTM EBIT for Pieris Pharmaceuticals?
Pieris Pharmaceuticals all-time high TTM earnings before interest & taxes is -$5800.00
What is Pieris Pharmaceuticals TTM EBIT year-on-year change?
Over the past year, PIRS TTM earnings before interest & taxes has changed by -$3.22 M (-21.64%)